(Q33205530)

23 July 2017

title

Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma (English)

1 reference

23 July 2017

0 references

1 reference

1 reference

1 reference

12

David T Curiel

1 reference

23 July 2017

5

Paul Dent

1 reference

23 July 2017

Charles A Leath

1

1 reference

23 July 2017

Manjula Kataram

2

1 reference

23 July 2017

Pradeep Bhagavatula

3

1 reference

23 July 2017

Rahul V Gopalkrishnan

4

1 reference

23 July 2017

Paul B Fisher

6

1 reference

23 July 2017

Alexander Pereboev

7

1 reference

23 July 2017

Delicia Carey

8

1 reference

23 July 2017

Irina V Lebedeva

9

1 reference

23 July 2017

Hidde J Haisma

10

1 reference

23 July 2017

Ronald D Alvarez

11

1 reference

23 July 2017

Parameshwar J Mahasreshti

13

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

23 July 2017

1 reference

23 July 2017

volume

94

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

352-362

1 reference

Gene therapy: ovarian carcinoma as the paradigm

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Adenoviral-mediated suicide gene therapy for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Gene therapy and ovarian cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

A phase I study of recombinant adenovirus vector-mediated delivery of an anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Why did p53 gene therapy fail in ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Targeted gene therapy of ovarian cancer using an ovarian-specific promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Interleukin-10 and related cytokines and receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Adenovirus-mediated in vivo gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Adenovirus gene therapy for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Adenoviruses in oncology: a viable option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Immune regulation by CD40-CD40-l interactions - 2; Y2K update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.028

10.1016/J.YGYNO.2004.04.028

7 January 2021

Identifiers

DOI

1 reference

23 July 2017

1 reference